Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders ...

Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people ...

As we approach another year of groundbreaking research in cancer care and significant treatment innovations, various companies are taking the ...

作者：范志红中国农业大学营养与健康系研究员，北京食品营养与人类健康高精尖中心岗位科学家，食品科学博士，注册营养师。“范志红_原创营养信息”自媒体作者；中国食品科技学会理事；中国营养学会食物与烹饪营养分会副主委；中国老年学与老年医学学会老年营养与食品分 ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...

According to H&B nutritionist Chandni Vadgama: “Nosediving blood sugar causes your energy levels to drop, and your brain ...